Safeguard Scientifics, Inc. New (SFE): Price and Financial Metrics
SFE Stock Price Chart Interactive Chart >
SFE Price/Volume Stats
| Current price | $7.72 | 52-week high | $8.78 |
| Prev. close | $7.88 | 52-week low | $4.43 |
| Day low | $7.52 | Volume | 179,800 |
| Day high | $7.98 | Avg. volume | 107,064 |
| 50-day MA | $7.05 | Dividend yield | N/A |
| 200-day MA | $6.44 | Market Cap | 161.29M |
Safeguard Scientifics, Inc. New (SFE) Company Bio
Safeguard Scientifics is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. The company was founded in 1953 and is based in Wayne, Pennsylvania.
Latest SFE News From Around the Web
Below are the latest news stories about Safeguard Scientifics Inc that investors may wish to consider to help them evaluate SFE as an investment opportunity.
Safeguard Scientifics reports Q4 resultsSafeguard Scientifics (SFE): Q4 GAAP EPS of -$0.35.Cash and cash equivalents of $15.6MPress Release... |
Safeguard Scientifics To Release Fourth Quarter And Full Year Financial Results On Thursday, March 4thSafeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the fourth quarter and full year ended December 31, 2020 prior to market open on Thursday, March 4, 2021. |
Safeguard Scientifics To Host A Virtual Discussion With Prognos HealthRADNOR, Pa. , Feb. 11, 2021 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE: SFE ) ("Safeguard" or the "Company") announced that it will host a virtual discussion with Sundeep Bhan, CEO of Prognos Health at 10:00 a.m. ET on Tuesday, February 23, 2021. In a continued effort to provide shareholders with additional information about Safeguard's ownership interests, Dr. Gary Kurtzman will lead a discussion with Mr. Bhan about Prognos Health. Safeguard first provided capital to Prognos in 2011 and has participated in multiple follow-on funding rounds aggregating to $12.6 million of funded capital and a 28% ownership interest. Mr. Bhan is a serial entrepreneur dedicated to improving health using technology. He is currently the CEO and Co-founder of Prognos Health, a leading healthcare platf... |
Safeguard Scientifics Inc (SFE) Q3 2020 Earnings Call TranscriptGood morning, and thank you for joining us for this update on Safeguard Scientifics' third quarter 2020 financial results. Joining me on today's call and webcast are Robert Rosenthal, Safeguard's Executive Chairman of the Board; Eric Salzman, Safeguard's Chief Restructuring Officer; and Mark Herndon, Safeguard's Chief Financial Officer. |
Safeguard Scientifics Announces Third Quarter 2020 Financial ResultsSafeguard Scientifics, Inc. (NYSE: SFE) ("Safeguard" or the "Company") today announced financial results for the three months and nine months ended September 30, 2020. |
SFE Price Returns
| 1-mo | -4.22% |
| 3-mo | 15.74% |
| 6-mo | 28.03% |
| 1-year | -12.37% |
| 3-year | -39.92% |
| 5-year | -35.07% |
| YTD | 21.00% |
| 2020 | -41.89% |
| 2019 | 27.38% |
| 2018 | -23.04% |
| 2017 | -16.73% |
| 2016 | -7.31% |
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...